RxDoctor Payments DataLook up a doctor →

Divya Batra, MD

Family Medicine · Quincy, ILNPI 1780896381

Payments from drug & device makers

$444,070in general payments, 2019–2025

Across 840 payments — averaging $528.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$215K
  • AstraZeneca$152K
  • Astrazeneca UK Limited$38K
  • Abbott$29K
  • AbbVie$2K
  • Amgen$1K
  • plus $6K from 40 others

What the payments were for

  • Consulting fees$140%
  • Food & beverage$10,35998%
  • Education$1912%
  • Other$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$444,070 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$2,462
Medicare patients
16
Services billed
621

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin63$58,380
OzempicSemaglutide45$51,095
TrulicityDulaglutide33$31,338
XareltoRivaroxaban41$30,824
JanuviaSitagliptin Phosphate29$29,746
FarxigaDapagliflozin Propanediol41$25,890
MounjaroTirzepatide18$21,776
EliquisApixaban32$19,554
KerendiaFinerenone28$19,087
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$13,834
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$12,555
MyrbetriqMirabegron17$9,190
DapagliflozinDapagliflozin Propanediol15$8,267
Tresiba Flextouch U-100Insulin Degludec13$6,564
SymbicortBudesonide/Formoterol Fumarate26$6,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$445$58,38063 claims
Lilly USA, LLCTrulicity, Mounjaro$937$53,11551 claims
Novo NordiskOzempic$1,095$51,09545 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$152,325$44,64787 claims
Johnson & JohnsonXarelto$173$30,82441 claims
PfizerEliquis, Paxlovid$498$20,99843 claims
BayerKerendia$309$19,08728 claims
GSKTrelegy Ellipta$215,492$13,83422 claims
Astellas Pharma US IncMyrbetriq$356$9,19017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Quincy

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →